SOURCE: Bollinger Report

April 23, 2012 09:00 ET

A Forward Look, the Year Ahead -- Featured Research on Anthera Pharmaceuticals, Inc. and AstraZeneca plc (ADR)

HONG KONG--(Marketwire - Apr 23, 2012) - Today, introduced featured coverage of Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) and AstraZeneca plc (ADR) (NYSE: AZN). Full research reports are available to readers at:

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Bollinger Report screened and selected Anthera Pharmaceuticals, Inc. for its current position within the healthcare industry. Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. As of December 31, 2010, Anthera had one Phase 3 clinical program, varespladib, and two Phase 2 clinical programs, A-623 and A-001. A copy of this report featuring Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) is available at:

Bollinger Report is featuring AstraZeneca plc (ADR) for its changing role within the healthcare industry. AstraZeneca plc (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. To download researches and analysis on AstraZeneca plc (ADR) (NYSE: AZN) we welcome investors to visit:

About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.

Contact Information